Alzheimer's Disease Trial, Not Yet Recruiting NCT07658430 Sponsor: Southwest Hospital, China Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Not Yet Recruiting

NCT07658430
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 50 and 80 years old, male or female.
  • People who have been clinically diagnosed with moderate probable Alzheimer's disease based on recognised diagnostic guidelines (NIA-AA criteria).
  • People whose score on a standard memory and thinking test (called the MMSE) falls between 10 and 20 out of 30 at the start of the trial.
  • People who have been experiencing cognitive decline for at least 6 months.
  • People who have been on a stable dementia medication routine for more than 6 months without clear improvement.
  • People who are able to complete memory and thinking assessments, a blood test, and a type of brain scan that looks for Alzheimer's-related proteins (Aβ-PET).
  • People who have a reliable caregiver who can attend follow-up appointments and help with assessments.
  • People for whom either the participant themselves, or their legal representative, is willing to sign a consent form agreeing to take part.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with serious heart, liver, kidney, breathing, or blood system problems that would make surgery or anaesthesia too risky.
  • People who have a history of brain surgery, serious head injury, stroke, brain tumour, or other conditions affecting the brain or nervous system.
  • People diagnosed with another type of dementia, such as vascular dementia, frontotemporal dementia, Lewy body dementia, or a mixed type.
  • People with a mental health condition that requires long-term medication that could affect the results of cognitive testing.
  • People for whom a PET brain scan is not medically suitable, or who have an allergy to contrast agents used in imaging.
  • People with an active infection, a current or active cancer diagnosis, or a severe illness causing significant physical decline.
  • People who are pregnant or breastfeeding.
  • People who have taken part in another interventional clinical trial within the 3 months before enrolling.
  • People who are unlikely to be able to follow the trial schedule or complete the required follow-up visits.
  • People whom the trial investigators consider unsuitable for any other reason (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8602368765911

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Southwest Hospital, China
Registry
ClinicalTrials.gov
Start date
1 July 2026
Est. completion
30 June 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in CDR-SB score from baseline to 12 months after randomization

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov